{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:32:32Z","timestamp":1789065152891,"version":"build-2803163510"},"reference-count":7,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,6,7]],"date-time":"2005-06-07T00:00:00Z","timestamp":1118102400000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Emerg Medicine Australasia"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recreational use of amphetamines is common in Australia and New Zealand when compared with other developed nations. The clinical effects are variable because of the potential of these drugs to increase the proportion of different biogenic amines in the central nervous system (CNS). The substances affected are adrenaline, noradrenaline, serotonin and dopamine. Movement disorders represent one of the less common presentations of amphetamine toxicity but one that health care workers should be aware of nonetheless.<\/jats:p>","DOI":"10.1111\/j.1742-6723.2005.00735.x","type":"journal-article","created":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T11:07:37Z","timestamp":1284548857000},"page":"277-280","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Amphetamine\u2010induced movement disorder"],"prefix":"10.1111","volume":"17","author":[{"given":"Michael A","family":"Downes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,6,7]]},"reference":[{"key":"e_1_2_5_2_2","volume-title":"Avery's Drug Treatment","author":"Speight TM","year":"1997"},{"key":"e_1_2_5_3_2","volume-title":"Goldfranks Toxicologic Emergencies","author":"Goldfrank LR","year":"2002"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-6757(88)90050-2"},{"key":"e_1_2_5_5_2","first-page":"986.","article-title":"Methamphetamine induced choreoathetosis and rhabdomyolysis","volume":"121","author":"Sperling LS","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.143.3.300"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563659709001175"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.135.2.252"}],"container-title":["Emergency Medicine Australasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-6723.2005.00735.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-6723.2005.00735.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:12:24Z","timestamp":1697325144000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-6723.2005.00735.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1742-6723.2005.00735.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-6723.2005.00735.x","archive":["Portico"],"relation":{},"ISSN":["1742-6731","1742-6723"],"issn-type":[{"value":"1742-6731","type":"print"},{"value":"1742-6723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"2005-06-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}